AR and posterior cortical atrophy: Interestingly, Cucchiara and coworkers recently reported that degarelix significantly decreases the proliferation of C4–2B MDVR (enzalutamide resistant, expressing high levels of the AR splice variant AR-V7, after a long exposure to the AR antagonist) PCa cells.